NYSE: CLS

CELESTICA INC

CIK 0001030894 · Information Technology · SIC 3672 · Printed Circuit Boards

Mega Revenue $12.4B Assets $9.8B as of Aug 7, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (GTM 10-Q) is open in full — no account needed.

8-K Filed Aug 7, 2026 · Period ending Aug 5, 2026

Summary not yet generated.

424B5 Filed Aug 6, 2026

Summary not yet generated.

Partner

Trade CLS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

424B5 Filed Aug 5, 2026

Summary not yet generated.

10-Q Filed Jul 27, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jul 27, 2026 · Period ending Jul 27, 2026

Summary not yet generated.

8-K Filed Jul 6, 2026 · Period ending Jul 6, 2026

Summary not yet generated.

8-K Filed May 19, 2026 · Period ending May 19, 2026

Summary not yet generated.

10-Q Filed Apr 27, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Feb 27, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed Mar 3, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

424B3 Filed Oct 24, 2006

Summary not yet generated.

424B3 Filed Nov 15, 2004

Summary not yet generated.

424B3 Filed Jun 30, 2004

Summary not yet generated.

424B4 Filed May 24, 2001

Summary not yet generated.

Latest financial statements

From 10-Q filed Jul 27, 2026 (period ending Jun 30, 2026). SEC XBRL (companyfacts) — not generated by the model.

SEC XBRL

Consolidated Statements of Operations (Unaudited)

Description Q2 ended Jun 30, 2026 Q1 ended Mar 31, 2026
Revenue:
Total revenue / net sales 4,699 4,047
Cost of revenue / cost of sales 4,121 3,610
Gross profit 577.5 437.2
Operating expenses:
Research and development 46.3 41.2
Selling, general and administrative 58.1 117.4
Other operating expenses, net 14.8 6.5
Operating income 458.3 272.1
Interest expense 21.2 16.0
Other income/(expense), net 0.7 0.2
Income before income taxes 441.6 256.3
Income tax expense/(benefit) 72.8 44.0
Net income 368.8 212.3
Basic earnings per share 3.21 1.85
Diluted earnings per share 3.17 1.83

Consolidated Balance Sheets (Unaudited)

Description Jun 30, 2026 Mar 31, 2026
Current assets:
Cash and equivalents 535.7 378.0
Inventories 459.7 285.2
Prepaid expenses and other current assets 298.7 178.6
Other current assets 6,280 5,555
Total current assets 7,574 6,397
Operating lease right-of-use assets, net 152.7 149.8
Finite-lived intangible assets, net 244.9 255.6
Goodwill 332.9 333.0
Deferred income taxes and other assets 206.2 182.3
Other long-term assets 1,277 942.4
TOTAL ASSETS 9,788 8,260
Current liabilities:
Current portion of long-term debt 26.4 25.9
Accounts payable 3,820 3,088
Current portion of operating lease liabilities 32.5 33.0
Income taxes payable 202.0 174.4
Deferred revenue, current 481.4 388.7
Other current liabilities 1,618 1,371
Total current liabilities 6,180 5,081
Long-term debt 784.0 746.5
Operating lease liabilities 138.3 134.8
Deferred income taxes and other liabilities 40.5 40.1
Other long-term liabilities 165.6 159.8
Total liabilities 7,308 6,162
Shareholders' equity:
Treasury stock 20.7 20.9
Total shareholders' equity 2,480 2,098
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 9,788 8,260

Consolidated Statements of Cash Flows (Unaudited)

Description Q2 ended Jun 30, 2026 Q1 ended Mar 31, 2026
Operating Activities:
Net cash from operating activities 410.9 356.3
Investing Activities:
Net cash from investing activities (266.3) (218.4)
Financing Activities:
Net cash from financing activities 13.1 (355.5)

Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗